Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Clinical Genetics · Trisomy 18

Can Blood Testing Miss Mosaic Trisomy 18? Other Tissue Tests

At a Glance

A normal blood test does not completely rule out mosaic trisomy 18 because the extra chromosome may be present in other tissues but absent from blood. A genetics team may consider cheek cells, skin cells, or tissue already removed during necessary surgery if the result could change care.

Yes, a postnatal diagnostic blood test—like a karyotype or a chromosomal microarray—can sometimes miss mosaic trisomy 18. If a person has physical signs or medical issues (often called clinical findings) that suggest a genetic condition, but their blood test comes back normal, it is possible that the extra chromosome 18 is present in other tissues of their body but not in their blood [1][2]. However, a normal result might also mean they truly do not have trisomy 18, and a different diagnosis is the cause.

Understanding Different Genetic Tests

Genetic tests have different strengths and limitations when looking for a mosaic condition (where some cells have an extra chromosome and some do not).

  • Karyotype: A traditional test that takes a picture of the chromosomes to count them. It requires cells to be grown (cultured) in a lab. It can miss mosaicism if the laboratory only examines a small number of cells, or if the typical cells grow faster in the lab and “outcompete” the trisomy 18 cells during culture [3][4].
  • Chromosomal Microarray (CMA): This test checks the DNA for missing or extra pieces. It usually does not require cells to be grown in a lab, which avoids culture bias. However, a microarray has a limit on how small of a mosaic fraction it can detect and can miss low levels of mosaicism [5][3].
  • FISH (Fluorescence In Situ Hybridization): This test uses fluorescent probes to light up and count specific chromosomes (like chromosome 18) in individual cells. It is often used on uncultured cells to look for low-level mosaicism [6].

None of these tests is perfectly sensitive in every situation, and every laboratory has a different detection limit.

Why Might Blood Be Normal?

When an embryo first begins to grow, all of its cells multiply. If a change (like an extra chromosome) happens in some cells but not others, the resulting cell lines (populations of cells) can be distributed unevenly throughout the body as the fetus develops [2][7].

Because of this uneven distribution, a person might have a significant number of cells with the extra chromosome in their internal organs or skin, but very few or none in their bloodstream [8]. Importantly, the level of mosaicism found in the blood does not tell doctors how much is in the rest of the body, and it cannot reliably predict the severity of the person’s medical condition or which organs are affected [9][7].

Testing Other Tissues

Because a normal blood test does not guarantee the rest of the body is normal, a clinical genetics team may recommend testing a different tissue if they still strongly suspect mosaic trisomy 18. This is not done automatically, but rather to answer a specific medical question [2].

  • Buccal (Cheek) Swab: A simple swab of the inside of the cheek collects a different population of cells than a blood draw. Testing these cheek cells (often using FISH) can sometimes reveal a mosaic cell line that the blood test missed [7][6].
  • Skin Fibroblasts: A doctor may perform a minor skin biopsy to test fibroblasts (connective tissue cells). The biopsy involves a small procedure, often with local numbing, that leaves a tiny scar. Testing these cells may detect or help confirm mosaic trisomy 18 in patients who have undetectable levels in blood or cheek swabs [10][8].
  • Other Surgical Tissues: If a patient is already having a clinically necessary surgery, the genetics team and surgeons can coordinate in advance to send a small piece of the removed tissue for genetic testing. Surgery should never be performed or delayed solely to get a genetic sample.

Limitations of Additional Testing

Every tissue specimen has limitations. A cheek swab or skin biopsy might still fail to detect mosaicism if the abnormal cells are present at extremely low levels or simply happen to be absent from that specific spot [11]. Furthermore, skin biopsies require the cells to be cultured in a lab, which carries the risk of culture bias where normal cells grow faster than the trisomy 18 cells [3].

A normal result from a cheek swab or skin biopsy simply means the extra chromosome was not found in that specific sample—it does not definitively prove that the extra chromosome is absent from every organ [11][8].

Ultimately, testing another tissue is a specialized decision. Families should work with a medical genetics team to decide if more testing is helpful, while continuing any necessary medical care or symptom management in the meantime. Waiting for a genetic diagnosis should not delay treatment for heart, feeding, or developmental needs.

Common questions in this guide

Can a normal blood test rule out mosaic trisomy 18?
No. Mosaic trisomy 18 can be distributed unevenly among the body’s tissues, so blood may contain few or no cells with the extra chromosome. A normal blood result can also mean the condition is absent or that another diagnosis explains the findings.
What tests can look for mosaic trisomy 18 when blood is normal?
A clinical genetics team may consider a cheek-cell test, skin-cell testing after a small biopsy, or testing tissue already removed during medically necessary surgery. FISH can count chromosome 18 in individual cells, while microarray and karyotype assess chromosome material in different ways. Each test has a different ability to detect low-level mosaicism.
Which tissue can be tested outside the blood?
A cheek swab collects cells from inside the mouth and may show mosaicism not found in blood. A skin biopsy can provide fibroblasts, or connective-tissue cells, for testing. These options are considered for a specific medical reason; surgery should not be done or delayed solely to obtain a genetic sample.
Does the amount of mosaic trisomy 18 in blood predict how severe the condition is?
No. The proportion of cells with an extra chromosome in blood does not reliably show how many affected cells are in other tissues or which organs are involved. It also cannot reliably predict the person’s medical needs or overall severity.
Can a cheek swab or skin biopsy also miss mosaic trisomy 18?
Yes. The abnormal cells may be present at a very low level or may not be present in the particular spot that was sampled. A normal cheek or skin result means the extra chromosome was not found in that sample; it does not prove that every tissue is unaffected.
When is additional tissue testing worth considering?
The genetics team usually weighs whether a result would change medical management, along with the limitations and burden of collecting another sample. Additional testing is not automatic, and necessary care for heart, feeding, or developmental needs should continue without waiting for a genetic result.

Get notified when new evidence is published on Trisomy 18 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Detection of mosaic chromosomal alterations in children with severe developmental disorders recruited to the DDD study.

    Eberhardt RY, Wright CF, FitzPatrick DR, et al.

    Genetics in medicine open 2023; (1(1)):100836 doi:10.1016/j.gimo.2023.100836.

    PMID: 39346101
  2. 2

    Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 18 at amniocentesis in a pregnancy with a favorable fetal outcome and maternal uniparental disomy 18.

    Chen CP, Su JW, Chern SR, et al.

    Taiwanese journal of obstetrics & gynecology 2022; (61(4)):684-689 doi:10.1016/j.tjog.2022.05.005.

    PMID: 35779922
  3. 3

    Prenatal Diagnosis of Chromosomal Mosaicism in 18,369 Cases of Amniocentesis.

    Kang H, Wang L, Xie Y, et al.

    American journal of perinatology 2024; (41(S 01)):e2058-e2068 doi:10.1055/s-0043-1770163.

    PMID: 37336233
  4. 4

    Genetic analysis of a fetus with mosaic trisomy 15 with false-negative result in prenatal amniotic fluid karyotype analysis.

    Li X, Peng Y, Liu W, et al.

    Taiwanese journal of obstetrics & gynecology 2025; (64(6)):1069-1075 doi:10.1016/j.tjog.2025.04.021.

    PMID: 41213756
  5. 5

    Should prenatal chromosomal microarray analysis be offered for isolated fetal growth restriction? A French multicenter study.

    Monier I, Receveur A, Houfflin-Debarge V, et al.

    American journal of obstetrics and gynecology 2021; (225(6)):676.e1-676.e15 doi:10.1016/j.ajog.2021.05.035.

    PMID: 34058167
  6. 6

    Mosaic trisomy 18 at amniocentesis associated with a favorable fetal outcome in a pregnancy.

    Chen CP, Hsu TY, Tsai CC, et al.

    Taiwanese journal of obstetrics & gynecology 2022; (61(4)):690-694 doi:10.1016/j.tjog.2022.05.006.

    PMID: 35779923
  7. 7

    Prenatal diagnosis of mosaic trisomy 18 and maternal uniparental disomy 18 by amniocentesis in a pregnancy associated with cytogenetic discrepancy in various tissues and a favorable fetal outcome.

    Chen CP, Wu FT, Pan YT, et al.

    Taiwanese journal of obstetrics & gynecology 2023; (62(4)):606-610 doi:10.1016/j.tjog.2023.05.012.

    PMID: 37407205
  8. 8

    Complex mosaic form of trisomy chromosome 18 and monosomy chromosome X in a girl with esophageal atresia and mild developmental delay: Diagnostic and therapeutic challenge and a review of literature.

    Chrzanowska J, Oparska A, Wróblewska A, et al.

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2026; (35(7)):1307-1312 doi:10.17219/acem/221563.

    PMID: 42267868
  9. 9

    Phenotypic Spectrum of Trisomy 18 Mosaicism: a New Patient and Literature Review.

    Sun W, Wang L, Liu T, et al.

    Clinical laboratory 2023; (69(3)) doi:10.7754/Clin.Lab.2022.220610.

    PMID: 36912299
  10. 10

    Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation.

    Motta S, Sala D, Sala A, et al.

    American journal of medical genetics. Part A 2016; (170(3)):777-80 doi:10.1002/ajmg.a.37504.

    PMID: 26701824
  11. 11

    Phenotypic extremes in liveborn monozygotic twins with mosaic Edwards syndrome.

    Bussmann N, Cunningham K, Green A, Ryan CA

    BMJ case reports 2015; (2015()).

    PMID: 26561224

This page explains why blood testing may miss mosaic trisomy 18 and what additional tissue testing can show for informational purposes only; it does not replace advice from your clinical genetics team.